3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Motor Activity
3
Sleep Wake Disorders
2
Overweight
2
Ovarian Neoplasms
2
Obesity
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Weight Loss
1
Urinary Bladder Neoplasms
1
Thyroid Cancer, Papillary
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Kidney Neoplasms
1
Intermittent Fasting
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Head and Neck Carcinoma
1
Feeding Behavior
1
Fatigue
1
Fasting
1
Endometrial Neoplasms
1
Depressive Disorder
1
Depression
1
Castration-Resistant Prostate Cancer (CRPC)
1
Interventions
Imatinib Mesylate
6
Sunitinib
4
ripretinib
2
regorafenib
2
Specimen Handling
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
IDRX-42
2
trastuzumab deruxtecan
1
pemigatinib
1
olverembatinib
1
envafolimab
1
atezolizumab
1
apatinib
1
Temozolomide
1
Surgical Instruments
1
Sorafenib
1
Rogaratinib
1
Nivolumab
1
Midazolam
1
Laparoscopy
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Biopsy
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
Counseling
×
90 days
×
Clear all
No trials found.